To access this element change to forms mode OFF
Grant Award View - GA207619
Targeting dysregulated transcription in cancer through...
GA ID:
GA207619
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
3-Nov-2021
Publish Date:
4-Jan-2022
Category:
Medical Research
Grant Term:
1-Jan-2022 to 31-Dec-2025
Value (AUD):
$849,454.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 20/21 1.1 Health and Medical Research
Grant Program:
Ideas Grants
Grant Activity:
Targeting dysregulated transcription in cancer through Cyclin-Dependent-Kinase 11
Purpose:
Many proteins cooperate to carefully control which genes are ‘on’ or ‘off’ in our cells. Defects in gene control that cause cells to grow faster and to live longer than normal give rise to cancer. I will investigate the activity of a group of proteins called Cyclin-dependent-kinases (CDKs), that are essential for ensuring proper gene control and are essential for cancer cells to survive. This will allow us to design better strategies to block the activity of CDKs to kill cancer cells.
GO ID:
GO Title:
2021 Ideas Grants
Internal Reference ID:
2021/GNT2012371
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Melbourne
Recipient ABN:
84 002 705 224
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
ACT, VIC, Overseas
Postcode:
Multiple
Country:
AUSTRALIA, GERMANY